414 related articles for article (PubMed ID: 25445538)
1. Resveratrol and diabetes: from animal to human studies.
Szkudelski T; Szkudelska K
Biochim Biophys Acta; 2015 Jun; 1852(6):1145-54. PubMed ID: 25445538
[TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic effects of resveratrol.
Szkudelski T; Szkudelska K
Ann N Y Acad Sci; 2011 Jan; 1215():34-9. PubMed ID: 21261639
[TBL] [Abstract][Full Text] [Related]
3. The role of resveratrol in diabetes and obesity associated with insulin resistance.
Hoca M; Becer E; Vatansever HS
Arch Physiol Biochem; 2023 Apr; 129(2):555-561. PubMed ID: 33719825
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and diabetes: A critical review of clinical studies.
Öztürk E; Arslan AKK; Yerer MB; Bishayee A
Biomed Pharmacother; 2017 Nov; 95():230-234. PubMed ID: 28843911
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol treatment restores peripheral insulin sensitivity in diabetic mice in a sirt1-independent manner.
González-Rodríguez Á; Santamaría B; Mas-Gutierrez JA; Rada P; Fernández-Millán E; Pardo V; Álvarez C; Cuadrado A; Ros M; Serrano M; Valverde ÁM
Mol Nutr Food Res; 2015 Aug; 59(8):1431-42. PubMed ID: 25808216
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?
de Ligt M; Timmers S; Schrauwen P
Biochim Biophys Acta; 2015 Jun; 1852(6):1137-44. PubMed ID: 25446988
[TBL] [Abstract][Full Text] [Related]
7. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.
Palsamy P; Subramanian S
J Cell Physiol; 2010 Aug; 224(2):423-32. PubMed ID: 20333650
[TBL] [Abstract][Full Text] [Related]
8. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.
Goh KP; Lee HY; Lau DP; Supaat W; Chan YH; Koh AF
Int J Sport Nutr Exerc Metab; 2014 Feb; 24(1):2-13. PubMed ID: 23918588
[TBL] [Abstract][Full Text] [Related]
9. Application of resveratrol in diabetes: rationale, strategies and challenges.
Bagul PK; Banerjee SK
Curr Mol Med; 2015; 15(4):312-30. PubMed ID: 25941821
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle.
Tran HT; Liong S; Lim R; Barker G; Lappas M
PLoS One; 2017; 12(3):e0173373. PubMed ID: 28278187
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol, obesity and diabetes.
Szkudelska K; Szkudelski T
Eur J Pharmacol; 2010 Jun; 635(1-3):1-8. PubMed ID: 20303945
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
Chi TC; Chen WP; Chi TL; Kuo TF; Lee SS; Cheng JT; Su MJ
Life Sci; 2007 Apr; 80(18):1713-20. PubMed ID: 17346750
[TBL] [Abstract][Full Text] [Related]
13. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
14. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
Zordoky BN; Robertson IM; Dyck JR
Biochim Biophys Acta; 2015 Jun; 1852(6):1155-77. PubMed ID: 25451966
[TBL] [Abstract][Full Text] [Related]
15. Diabetic complications in pregnancy: is resveratrol a solution?
Singh CK; Kumar A; Lavoie HA; Dipette DJ; Singh US
Exp Biol Med (Maywood); 2013 May; 238(5):482-90. PubMed ID: 23436883
[TBL] [Abstract][Full Text] [Related]
16. Novel strategies for preventing diabetes and obesity complications with natural polyphenols.
Carpene C; Gomez-Zorita S; Deleruyelle S; Carpene MA
Curr Med Chem; 2015; 22(1):150-64. PubMed ID: 25139462
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol protects against methylglyoxal-induced hyperglycemia and pancreatic damage in vivo.
Cheng AS; Cheng YH; Lee CY; Chung CY; Chang WC
Nutrients; 2015 Apr; 7(4):2850-65. PubMed ID: 25884658
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol improves hepatic insulin signaling and reduces the inflammatory response in streptozotocin-induced diabetes.
Sadi G; Pektaş MB; Koca HB; Tosun M; Koca T
Gene; 2015 Oct; 570(2):213-20. PubMed ID: 26071184
[TBL] [Abstract][Full Text] [Related]
19. Regulation of signaling molecules associated with insulin action, insulin secretion and pancreatic β-cell mass in the hypoglycemic effects of Korean red ginseng in Goto-Kakizaki rats.
Kim HY; Kim K
J Ethnopharmacol; 2012 Jun; 142(1):53-8. PubMed ID: 22543177
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes.
Poulsen MM; Fjeldborg K; Ornstrup MJ; Kjær TN; Nøhr MK; Pedersen SB
Biochim Biophys Acta; 2015 Jun; 1852(6):1124-36. PubMed ID: 25583116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
